Tag: acquisition
Synchron acquires equity stake in Acquandas
Endovascular brain-computer interface (BCI) technology firm Synchron has announced the acquisition of an equity stake in Acquandas—a leading technology provider specialising in state-of-the-art, high-precision components...
Axonics announces definitive agreement to be acquired by Boston Scientific
Axonics has announced that it has entered into a definitive agreement to be acquired by Boston Scientific Corporation for US$71 in cash per share,...
Nevro announces acquisition of Vyrsa Technologies
Nevro Corporation has announced that it has acquired Vyrsa Technologies—a privately held medical technology company focused on a minimally invasive treatment option for patients...
Boston Scientific to expand neuromodulation portfolio with Relievant Medsystems acquisition
Boston Scientific Corporation has today announced it has entered into a definitive agreement to acquire Relievant Medsystems—a privately held medical technology company that has...
Wallaby acquires phenox to accelerate global expansion in neurovascular space
Wallaby Medical today announced that it has acquired phenox GmbH—including phenox's femtos GmbH—for a total consideration of approximately €500 million including milestone payments.
The acquisition is...
Codman Neuro acquires Neuravi
Codman Neuro has announced the acquisition of Neuravi. This acquisition comes after the company’s recent acquisition of Pulsar Vascular, expanding its products for stroke...
Integra LifeSciences to acquire Codman Neurosurgery business from Johnson & Johnson
Integra LifeSciences Holdings Corporation has made a binding offer to acquire the Johnson & Johnson Codman Neurosurgery business for a price of US$1.045 billion in...
Abbott completes the acquisition of St Jude Medical
Abbott has now completed the acquisition of St Jude Medical. The Abbott press release announcing the completion of the acquisition said, “The transaction provides...
Codman Neuro announces acquisition of Pulsar Vascular Inc
Codman Neuro has announced the acquisition of Pulsar Vascular Inc, a privately-held company with breakthrough platform technology for the neurovascular treatment of complex aneurysms. DePuy...
